Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 15.01.19 in Vol 7, No 1 (2019): January

This paper is in the following e-collection/theme issue:

Works citing "Health Benefits and Cost-Effectiveness From Promoting Smartphone Apps for Weight Loss: Multistate Life Table Modeling"

According to Crossref, the following articles are citing this article (DOI 10.2196/11118):

(note that this is only a small subset of citations)

  1. Bates S, Bayley T, Norman P, Breeze P, Brennan A. A Systematic Review of Methods to Predict Weight Trajectories in Health Economic Models of Behavioral Weight-Management Programs: The Potential Role of Psychosocial Factors. Medical Decision Making 2020;40(1):90
    CrossRef
  2. Cleghorn CL, Wilson N, Nair N, Kvizhinadze G, Nghiem N, McLeod M, Blakely T. Health benefits and costs of weight-loss dietary counselling by nurses in primary care: a cost-effectiveness analysis. Public Health Nutrition 2020;23(1):83
    CrossRef
  3. Choi J, Baker E, Nalawade S, Lee H. Steps to Develop a Mobile App for Pain Assessment of Cancer Patients. CIN: Computers, Informatics, Nursing 2020;38(2):80
    CrossRef
  4. Drew J, Cleghorn C, Macmillan A, Mizdrak A. Healthy and Climate-Friendly Eating Patterns in the New Zealand Context. Environmental Health Perspectives 2020;128(1):017007
    CrossRef
  5. Barthow C, Hood F, McKinlay E, Hilder J, Cleghorn C, Huthwaite M, Weatherall M, Parry-Strong A, Pullon S, Gray B, Wickens K, Crane J, Krebs J. Food 4 Health - He Oranga Kai: Assessing the efficacy, acceptability and economic implications of Lactobacillus rhamnosus HN001 and β-glucan to improve glycated haemoglobin, metabolic health, and general well-being in adults with pre-diabetes: study protocol for a 2 × 2 factorial design, parallel group, placebo-controlled randomized controlled trial, with embedded qualitative study and economic analysis. Trials 2019;20(1)
    CrossRef